These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3319421)

  • 1. Anti-Candida drugs--the biochemical basis for their activity.
    Vanden Bossche H; Willemsens G; Marichal P
    Crit Rev Microbiol; 1987; 15(1):57-72. PubMed ID: 3319421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical basis for the activity and selectivity of oral antifungal drugs.
    Vanden Bossche H; Marichal P; Gorrens J; Coene MC
    Br J Clin Pract Suppl; 1990 Sep; 71():41-6. PubMed ID: 2091733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mode of action of anti-Candida drugs: focus on terconazole and other ergosterol biosynthesis inhibitors.
    Vanden Bossche H; Marichal P
    Am J Obstet Gynecol; 1991 Oct; 165(4 Pt 2):1193-9. PubMed ID: 1951574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal agents: mode of action in yeast cells.
    Carrillo-Muñoz AJ; Giusiano G; Ezkurra PA; Quindós G
    Rev Esp Quimioter; 2006 Jun; 19(2):130-9. PubMed ID: 16964330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arachidonic acid increases antifungal susceptibility of Candida albicans and Candida dubliniensis.
    Ells R; Kock JL; Van Wyk PW; Botes PJ; Pohl CH
    J Antimicrob Chemother; 2009 Jan; 63(1):124-8. PubMed ID: 18971215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interactions between 5-fluorocytosine and polyene antibiotics, resp. imidazole derivatives (author's transl)].
    Högl F; Raab W
    Mykosen; 1981 May; 24(5):261-74. PubMed ID: 6265772
    [No Abstract]   [Full Text] [Related]  

  • 7. [Investigation of quantitative and species composition and antifungal drug susceptibility of yeasts isolated from patients with generalized periodontitis complicated by candidosis].
    Kutsyk RV; Pavliuk TD
    Mikrobiol Z; 2003; 65(5):26-9. PubMed ID: 14723159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic antifungal activity of statin-azole associations as witnessed by Saccharomyces cerevisiae- and Candida utilis-bioassays and ergosterol quantification.
    Cabral ME; Figueroa LI; Fariña JI
    Rev Iberoam Micol; 2013 Jan; 30(1):31-8. PubMed ID: 23069981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulatory effect of cAMP on fungal ergosterol level and inhibitory activity of azole drugs.
    Sardari S; Mori Y; Kurosawa T; Daneshtalab M
    Can J Microbiol; 2003 May; 49(5):344-9. PubMed ID: 12897828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacology of agents used in the treatment of pulmonary mycoses.
    Borgers M; Vanden Bossche H; Cauwenbergh G
    Clin Chest Med; 1986 Sep; 7(3):439-52. PubMed ID: 3021382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition and interaction of cytochrome P450 of Candida krusei with azole antifungal drugs.
    Venkateswarlu K; Denning DW; Kelly SL
    J Med Vet Mycol; 1997; 35(1):19-25. PubMed ID: 9061581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of antifungal drugs on adherence of Candida albicans to buccal epithelial cells.
    Brenciaglia MI; Ghezzi MC; Cipriani P; Mancini C; Trancassini M
    Chemioterapia; 1986 Jun; 5(3):200-3. PubMed ID: 3521918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of the in vitro sensitivity of yeasts with the ATB-Fungus system].
    Martínez MM; Mendaza P; Daza RM; Sánchez G; Martín P; Martín JE; Portero F
    Rev Esp Quimioter; 1998 Sep; 11(3):251-3. PubMed ID: 9795312
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro susceptibility of oral Candida to seven antifungal agents.
    Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
    Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study of two systems for the determination of the sensitivity of yeasts to antifungal agents].
    de Montclos M; de Montclos H; Flandrois JP
    Pathol Biol (Paris); 1992 May; 40(5):495-9. PubMed ID: 1495833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of polyene antibiotics on protein synthesis by free and membrane-bound ribosomes of Candida albicans].
    Lishnevskaia EB; Belousova II; Rodygina TN; Tereshin IM
    Biokhimiia; 1976; 41(7):1169-75. PubMed ID: 793640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical targets for antifungal azole derivatives: hypothesis on the mode of action.
    Vanden Bossche H
    Curr Top Med Mycol; 1985; 1():313-51. PubMed ID: 3916772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The sensitivity of yeasts from the Candida genus isolated from cancer patients to polyene antifungals].
    Alves SH; Cury AE
    Rev Inst Med Trop Sao Paulo; 1992; 34(3):251-4. PubMed ID: 1342079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of antifungal resistance.
    Vanden Bossche H
    Rev Iberoam Micol; 1997 Jun; 14(2):44-9. PubMed ID: 16854169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of two different growth media on the postantifungal effect induced by polyenes on Candida species.
    Shu M; Ellepola AN; Samaranayake LP
    J Clin Microbiol; 2001 Jul; 39(7):2732-5. PubMed ID: 11427609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.